Introduction
============

Endometriosis is an enigmatic condition with an unknown etiology and poorly understood pathogenesis. It is defined by the presence of endometrial tissue external to the uterine cavity and women with endometriosis represent a high-risk population group for a large category of chronic conditions ([@b1-mmr-18-06-5053]). Familial association of endometriosis additionally suggests a genetic contribution to the disease and various genetic susceptibility loci have been identified by case-control studies as well as genome-wide association studies (GWAS) ([@b2-mmr-18-06-5053]).

Findings related to the co-morbidities of gynecological and non-gynecological diseases with endometriosis have been published thus far ([@b3-mmr-18-06-5053]). In this framework, diverse associations between endometriosis and other diseases were examined including autoimmune and endocrine disorders, cardiovascular diseases, benign gynecological conditions and various types of malignancy ([@b3-mmr-18-06-5053]). The latter is expected considering that endometriosis shares some characteristics with malignant tumors, such as invasion of local and distant organs, abnormal tissue growth, dysfunction of target organs, and genetic damage. Moreover, previous case reports studies emphasized on co-morbidities of endometriosis with various autoimmune disorders, including autoimmune alopecia universalis, autoimmune thyroiditis, multiple sclerosis (MS), and autoimmune progesterone dermatitis ([@b4-mmr-18-06-5053]). In addition, similarities between systemic lupus erythematosus (SLE) and endometriosis were detected upon a comparative evaluation of clinical and humoral immunologic abnormalities ([@b5-mmr-18-06-5053]).

At present, next generation sequencing gives the opportunity to look for less common variants with large effects. Prompted by our recent genetic analysis of a well-characterized, three-generation Greek family with seven affected women with surgically confirmed endometriosis ([@b6-mmr-18-06-5053]), we performed a whole exome sequencing (WES) in an attempt to identify rare, disease-associated exonic variants. In the present study, we report a unique case of a woman of this family with endometriosis, manifesting a co-morbidity of 13 non-gynecological diseases, including SLE, ankylosing spondylitis (AS), MS, bronchial asthma, Crohn\'s disease (CD), urinary bladder diverticulum, osteoporosis, multinodular goiter, cardiovascular disease, gastroesophageal reflux disease, malignant tumor of urinary bladder, Barrett\'s esophagus and bilateral cataract, whose history included infertile members suffering from endometriosis as well ([Table I](#tI-mmr-18-06-5053){ref-type="table"}). We also explored the potential explanations for the genetic associations between a high number of genes and various diseases, based on the data detected by WES.

Materials and methods
=====================

### Participants

We describe the case of a familial case of a 67-year-old female, who presented with a history of endometriosis and underwent surgical hysterectomy at 32 years of age, due to stage IV endometriosis ([@b6-mmr-18-06-5053]). Of interest, her mother had given birth to four children who had no gynecologic problems ([@b6-mmr-18-06-5053]). According to her obstetric and medical history she gave birth to three female offspring and, furthermore, she underwent four surgeries for endometriosis ([Table I](#tI-mmr-18-06-5053){ref-type="table"}). All three daughters were diagnosed surgically (laparotomy or laparoscopy) with endometriosis, and the disease was confirmed histologically from biopsies. Moreover, her grandaughters acquired endometriosis.

The age, gynecological and major non-gynecological chronic diseases are shown in [Table I](#tI-mmr-18-06-5053){ref-type="table"}. Osteoporosis, recurrent cystitis and urinary bladder diverticulum were evident after total hysterectomy with bilateral salpingo oophorectomy. At the age of 45, she acquired multinodular goiter. Two years later, the patient experienced the first episode of cardiovascular disease. At the age of 50, SLE was diagnosed, while within the next 12 years, four more autoimmune disorders were confirmed, namely AS, MS, bronchial asthma and CD. Apart from the aforementioned autoimmune diseases, the woman experienced malignant tumor of urinary bladder during the sixth decade of her life. The pathology report demonstrated transitional cell carcinoma and the patient underwent intrabladder chemotherapy cycles. The data were collected by the clinicians and pathologists reported the medical records, including surgical procedures and findings. The Ethics Committees of the Human Research at Venizeleio General Hospital of Heraklion (ECHR no.46/6686) (Heraklion, Greece) approved the overall study and a written informed consent was obtained from the patient.

### Whole exome sequencing

Genomic DNA was isolated from peripheral blood leukocytes by using the commercial kit (PureLink^®^ Genomic DNA mini kit; Invitrogen Life Technologies; Thermo Fisher Scientific, Inc., Waltham, MA, USA) according to the manufacturer\'s protocol. Exome sequencing was conducted using the AmpliSeq technology on Ion Proton platform (Thermo Fisher Scientific, Inc.). After sequence assembly using Torrent software, variant annotation was performed using ANNOVAR (hg19 reference; <http://annovar.openbioinformatics.org/en/latest/>). Variants were determined using Ion Proton protocol and confirmed using the Genome Analysis Toolkit pipeline.

Results
=======

### WES detected autoimmune disease-risk genotypes

The woman under study was found to be homozygous for the risk allele 'T' of the functional, SLE-, AS- and CD-associated rs2476601 SNP of *PTPN22* gene, coding for protein tyrosine phosphatase, non-receptor type 22 ([Table II](#tII-mmr-18-06-5053){ref-type="table"}). The protein coded by *PTPN22* gene contributes to the modulation of negative T-cell selection in the thymus and downregulation of autoreactive T cells in the periphery ([@b7-mmr-18-06-5053]).

The patient under study was heterozygous for both rs27434 and rs30187 SNPs of *ERAP1* gene, T/C and A/G, respectively. *ERAP1* gene encodes an endoplasmic reticulum aminopeptidase involved in peptide trimming before HLA class I presentation and has been associated with AS by GWAS ([@b8-mmr-18-06-5053]) as well as CD ([@b9-mmr-18-06-5053]). She was also heterozygous (A/G) for rs602662 *FUT2* SNP. *FUT2* codes for a protein that is responsible for secretion of the ABO histo-blood group antigens in the mucosa. Importantly, the heterozygous genotype A/G of rs602662 SNP has been previously associated with SLE, CD and AS ([@b9-mmr-18-06-5053],[@b10-mmr-18-06-5053]) with all three diseases appearing in the woman under investigation.

Furthermore, WES results showed that this woman was heterozygous for rs10781499 and rs4077515 SNPs of CARD9 as well as rs3197999 SNP of *MST1* gene, which have been associated with CD ([@b9-mmr-18-06-5053]--[@b11-mmr-18-06-5053]). Caspase recruitment domain (*CARD*) 9 is an important adapter protein that is widely expressed in various tissues including liver, spleen, bone marrow, brain, lung and peripheral blood and is closely associated with immune and inflammatory responses ([@b12-mmr-18-06-5053]). *MST1* is the basic gene for regulating cell apoptosis in Mammalian ste20-like protein kinase (MST) protein family ([@b13-mmr-18-06-5053]).

Interleukin 16 (IL16), which is also known as a lymphocyte chemoattractant factor, is a proinflammatory cytokine playing a decisive role in various immune and inflammatory responses, while it has also been referred as a causative factor for endometriosis and SLE ([@b14-mmr-18-06-5053]), probably by resulting in the aberrant expression of IL16. The woman under study was found to be heterozygous (G/T) for this SNP and, interestingly, G/T genotype of this SNP has been associated previously with SLE as well as CAD ([@b15-mmr-18-06-5053]), thus indicating that this polymorphism may contribute to the development of both diseases in this case.

### WES data for non-autoimmune diseases

Concerning the malignant tumor of urinary bladder identified in the patient, she was found to be heterozygous for rs10936599 SNP of *MYNN* gene located in 3q26.2 ([Table II](#tII-mmr-18-06-5053){ref-type="table"}), an SNP that has been confirmed by GWAS to be a disease-associated gene and may be used for the measure of inherited risk for bladder cancer (BC) ([@b16-mmr-18-06-5053]).

The woman under study was diagnosed with recurrent cystitis at the age of 33 years. Moreover, bronchial asthma manifested at the age of 62 years and was found to be homozygous A/A for the risk allele of rs6967330 of *CDHR3* gene, encoding cadherin-related family member 3 which is highly expressed in airway epithelium, which has been associated with an increased susceptibility for asthma ([@b17-mmr-18-06-5053]).

Apparently, numerous genotypes carrying the minor allele of already known SNPs as well as new gene polymorphisms (SNPs and indels) were detected through the conducted WES analysis. However, these data are not presented in detail considering that any speculation regarding a causative association of the observed polymorphisms with the disease pathogenesis has to be confirmed first by functional experiments.

Discussion
==========

Over a period of 30 years, 1,000 patients with endometriosis from two different geographic locations (USA and Greece) underwent surgical treatment for endometriosis by our colleagues. To the best of our knowledge and upon reviewing the literature, the woman under investigation in the present study represents the first reported case of familial endometriosis associated with 13 non-gynecological diseases. Thus, the woman acquired various non-gynecological conditions including cardiovascular disease, autoimmune diseases and non-gynecological cancer. Our overall findings suggest that women with severe familial endometriosis seem to have a higher risk of developing other chronic disorders. Interestingly, there are several epidemiological reports regarding the association of endometriosis with serious chronic diseases. We previously confirmed a correlation between endometriosis and asthma, in a group of 55 adolescent girls ([@b18-mmr-18-06-5053]), as well as with various autoimmune diseases, such as rheumatoid arthritis, hypothyroidism, SLE and MS ([@b19-mmr-18-06-5053]). Thus far, laparoscopically-confirmed endometriosis has been significantly associated with subsequent SLE but it remains unclear whether endometriosis itself, hysterectomy or any unidentified factors are related to the increased risk of SLE.

Notably, no history of smoking or alcohol consumption was reported for this woman. Considering that alcohol and smoking affect the development of many diseases evident in this patient i.e., bronchial asthma, BC, cardiovascular disease, it can be assumed that the genetic background rather than environmental life-style factors is of higher contribution in this case, thus adding more weight to the genetic contribution. It is worth noting given that there is a positive correlation between endometriosis and interstitial cystitis (IC) and between IC and BC. A hypothesis that may explain much of the patient\'s profile, suggests that endometriosis, IC, CD and airway problems (bronchial asthma) are linked to loss of epithelial/mesothelial barrier integrity ([@b20-mmr-18-06-5053]) and, therefore, inflammation could be considered as a natural immunologic response to this sensitivity.

Autoimmune diseases are complex diseases characterized by loss of self-tolerance, causing immune-mediated tissue destruction. A similar immunological alteration occurs in endometriosis, thus increasing the number and cytotoxicity of macrophages and leading to various abnormalities in the function and concentrations of B and T lymphocytes ([@b21-mmr-18-06-5053]). Endometriosis has been widely characterized as an inflammatory disease, showing a significant deregulation of the immune system at the injury site as well as the uterine cavity of women with endometriosis. Thus, there is growing evidence that women who experience one autoimmune disease are more likely to have additional autoimmune problems, probably due to underlying shared pathogenic pathways. Although the accumulating evidence that common genetic factors might predispose to multiple autoimmune diseases, there are no direct evidences to support clear causality implicating common genetic or environmental factors. Autoimmune diseases developed in the woman under discussion affect predominantly middle-aged women (35--45 years).

As far as the ocular complications are concerned, idiopathic macular hole usually appears after the age of 65 years, with 2/3 of the patients being women and is usually unilateral. Regarding cataract formation, it is known to mostly be related to older age, though other causes exist such as ocular trauma and ocular surgery, radiation, diabetes and prolonged steroid use as well as environmental and genetic predisposition ([@b22-mmr-18-06-5053]).

In conclusion, considering that the advent of high-throughput sequencing technologies has markedly expanded knowledge of genome-wide gene abnormalities, the WES data analysis supports the notion that endometriosis and various autoimmune diseases share possible common genetic and pathophysiological features. The notable number of co-morbidities observed reinforces the necessity for further studies, given that the high number of co-morbidities raises the question of a shared molecular/genetic pathogenic mechanism. If future studies confirm relationships between endometriosis and chronic diseases and/or identify more risk factors predisposing endometriosis patients to develop many non-gynecological diseases, the new findings will have important implications in the management and care of women with endometriosis by allowing physicians to make decision regarding relevant therapeutic approaches.
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###### 

Summary of gynecological and non-gynecological diseases in a patient with endometriosis.

  Age (years)   Obstetric and medical history
  ------------- -----------------------------------------------------------------------------
    67          Date of birth: 1951
                Menarche at the age of 11 years, regular menstrual cycles 26--28 days
                At the age of 15 years, first daughter (vaginal delivery)
                At the age of 19 years, second daughter (vaginal delivery)
                At the age of 25 years, third daughter (vaginal delivery)
                  +2 miscarriages \<10 weeks
                  No history of alcohol and smoking
                
                **Co-morbidities with non-gynecological chronic disorders**
                
    27          Diagnosis of endometriosis, bilateral endometrioma
                Between 27 and 32 years she underwent 4 surgeries for endometriosis
    32          Total hysterectomy with bilateral salpingo oophorectomy
    33          Recurrent cystitis, diagnosis and operation of urinary bladder diverticulum
    38          Osteoporosis
    45          Multinodular goiter
    47          Cardiovascular disease
    50          Systemic lupus erythematosus
    52          Ankylosing spondylitis
    54          Multiple sclerosis
    57          Gastro-esophageal reflux disease, diaphragmatocele
    60          Unilateral macular hole surgery in the eye
                Within 3 years, diagnosis and operation of bilateral cataract
    62          Crohn\'s disease, confirmed with biopsy
                Bronchial asthma
    66          Malignant tumor of urinary bladder: Transitional cell carcinoma
    67          Barrett\'s esophagus

###### 

Disease-associated genotypes for co-morbidities in the patient with endometriosis

  Disease            dbSNP ID     Genes      Function                                                          Genotype   Refs.
  ------------------ ------------ ---------- ----------------------------------------------------------------- ---------- -----------------------------------------------
  SLE, AS, CD        rs2476601    *PTPN22*   T-cell signaling; macrophage polarization; interferon signaling   TT         ([@b7-mmr-18-06-5053])
  AS, CD             rs27434      *ERAP1*    Antigen presentation                                              CT         ([@b9-mmr-18-06-5053])
  AS, CD             rs30187      *ERAP1*    Antigen presentation                                              AG         ([@b10-mmr-18-06-5053])
  SLE, AS, CD        rs602662     *FUT2*     A and B antigen synthesis pathway                                 AG         ([@b10-mmr-18-06-5053],[@b11-mmr-18-06-5053])
  SLE, CAD           rs11556218   *IL16*     Chemoattractant; modulator of T-cell activation                   GT         ([@b12-mmr-18-06-5053],[@b13-mmr-18-06-5053])
  CD                 rs10781499   *CARD9*    Activation of pro- and anti-inflammatory cytokines                CT         ([@b10-mmr-18-06-5053],[@b11-mmr-18-06-5053])
  CD                 rs4077515    *CARD9*    Activation of pro- and anti-inflammatory cytokines                AG         ([@b10-mmr-18-06-5053],[@b11-mmr-18-06-5053])
  CD                 rs3197999    *MST1*     Regulation of cell apoptosis                                      CT         ([@b11-mmr-18-06-5053])
  BC                 rs10936599   *MYNN*     Control of gene expression                                        CT         ([@b12-mmr-18-06-5053],[@b14-mmr-18-06-5053])
  Bronchial asthma   rs6967330    *CDHR3*    Calcium ion binding                                               AA         ([@b13-mmr-18-06-5053])

SLE, systemic lupus erythematosus; AS, ankylosing spondylitis; CD, Crohn\'s disease; CAD, cardiovascular disease; BC, bladder cancer.
